Literature DB >> 21850605

Accuracy of macroscopic intraoperative diagnosis of serosal invasion and risk of over- and underestimation in gastric carcinoma.

Oh Jeong1, Seong Yeop Ryu, Mi Ran Jeong, Jang Won Sun, Young Kyu Park.   

Abstract

BACKGROUND: Accurate intraoperative diagnosis of serosal invasion is a prerequisite for proper application of invasive procedures, such as intraperitoneal chemohyperthermia, for serosa positive gastric carcinomas.
METHODS: We reviewed the prospectively constructed data of 1,265 gastric cancer patients who underwent surgery between 2007 and 2009. Accuracies of macroscopic diagnoses of serosal invasion were determined by comparing with pathological findings. The risk factors of over- and underestimation of serosal invasion were analyzed in the univariate and multivariate model.
RESULTS: The accuracy of macroscopic intraoperative diagnosis of serosal invasion was 88%. Serosal invasion was underestimated in 34 of 187 serosa positive patients and overestimated in 117 of 1,078 serosa negative patients; a sensitivity and specificity of 82 and 89%, respectively. When pT1 tumors were excluded, the accuracy, sensitivity, and specificity of macroscopic diagnosis of serosal invasion were 71.5, 81.8, and 65.3%, respectively. Univariate and multivariate analysis revealed that a tumor size of >4 cm and preoperative CT finding of serosa positive were independent risk factors for macroscopic overestimation as serosal invasion in pT2 gastric cancer. Meanwhile, Borrmann type 1, preoperative CT finding of serosa negative, lesser/posterior surface location, and tumor size of <4 cm were independent risk factors for underestimation of serosal invasion in pT3 gastric carcinoma.
CONCLUSIONS: The macroscopic diagnosis of serosal invasion is largely consistent with pathological findings. However, great care should be taken with regard to the risk of over- and underestimation of serosal invasion when making a decision for invasive treatments based on macroscopic findings of serosal invasion.

Entities:  

Mesh:

Year:  2011        PMID: 21850605     DOI: 10.1007/s00268-011-1197-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

Review 1.  Imaging in local staging of gastric cancer: a systematic review.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

2.  Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial.

Authors:  W Yu; I Whang; H Y Chung; A Averbach; P H Sugarbaker
Journal:  World J Surg       Date:  2001-08       Impact factor: 3.352

3.  Recurrence following curative resection for gastric carcinoma.

Authors:  C H Yoo; S H Noh; D W Shin; S H Choi; J S Min
Journal:  Br J Surg       Date:  2000-02       Impact factor: 6.939

4.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

5.  Surgical treatment and prognosis of gastric cancer in 2,613 patients.

Authors:  Xiang-Fu Zhang; Chang-Ming Huang; Hui-Shan Lu; Xing-Yuan Wu; Chuang Wang; Guo-Xian Guang; Jian-Zhong Zhang; Chao-Hui Zheng
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

6.  Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.

Authors:  Y Kodera; Y Yamamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato
Journal:  J Surg Oncol       Date:  1999-10       Impact factor: 3.454

7.  Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer.

Authors:  W Yu; I Whang; A Averbach; D Chang; P H Sugarbaker
Journal:  Am Surg       Date:  1998-11       Impact factor: 0.688

Review 8.  A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

Authors:  Tristan D Yan; Deborah Black; Paul H Sugarbaker; Jacqui Zhu; Yutaka Yonemura; George Petrou; David L Morris
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

9.  Macroscopic intraoperative diagnosis of serosal invasion and clinical outcome of gastric cancer: risk of underestimation.

Authors:  Y Ichiyoshi; Y Maehara; S Tomisaki; H Oiwa; Y Sakaguchi; S Ohno; K Sugimachi
Journal:  J Surg Oncol       Date:  1995-08       Impact factor: 3.454

10.  Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.

Authors:  Kazuhiro Yasuda; Norio Shiraishi; Masafumi Inomata; Hidefumi Shiroshita; Koichi Izumi; Seigo Kitano
Journal:  Hepatogastroenterology       Date:  2007 Oct-Nov
View more
  8 in total

1.  Estimate or calculate? How surgeons rate volumes and surfaces.

Authors:  Jochen Schuld; Otto Kollmar; Roland Seidel; Catherine Black; Martin K Schilling; Sven Richter
Journal:  Langenbecks Arch Surg       Date:  2012-03-17       Impact factor: 3.445

2.  Intraoperative dissemination during gastrectomy for gastric cancer associated with serosal invasion.

Authors:  Yukio Tokumitsu; Shigefumi Yoshino; Michihisa Iida; Kiyoshi Yoshimura; Tomio Ueno; Shoichi Hazama; Masaaki Oka
Journal:  Surg Today       Date:  2014-08-14       Impact factor: 2.549

3.  Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer.

Authors:  Kenji Nakamura; Kohei Tajima; Kohei Kanamori; Kentaro Yatabe; Mika Ogimi; Tadashi Higuchi; Miho Yamamoto; Hitoshi Hara; Akihito Kazuno; Kazuhito Nabeshima; Eiji Nomura; Kazuo Koyanagi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

4.  The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer.

Authors:  B Zhao; D Mei; J Zhang; S Zou; Hn Lu; H Xu; B Huang
Journal:  Ann R Coll Surg Engl       Date:  2019-01-03       Impact factor: 1.891

5.  Impact of Intraoperative Macroscopic Diagnosis of Serosal Invasion in Pathological Subserosal (pT3) Gastric Cancer.

Authors:  Dong Jin Kim; Jun Hyun Lee; Wook Kim
Journal:  J Gastric Cancer       Date:  2014-12-26       Impact factor: 3.720

6.  T and N Staging of Gastric Cancer Using Dual-Source Computed Tomography.

Authors:  Zhao-Yong Xie; Rui-Mei Chai; Guo-Cheng Ding; Yi Liu; Ke Ren
Journal:  Gastroenterol Res Pract       Date:  2018-12-04       Impact factor: 2.260

7.  Prognostic significance of intraoperative macroscopic serosal invasion finding when it shows a discrepancy in pathologic result gastric cancer.

Authors:  Sang Yull Kang; Ho Sung Park; Chan-Young Kim
Journal:  Ann Surg Treat Res       Date:  2016-05-02       Impact factor: 1.859

8.  Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.

Authors:  Yue Kang; Shenglong Li; Qinghong Ge; Xinran Liu; Zhenyu Yang; Yingwei Xue; Fujing Wang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.